KNAPP MEDICAL CENTER
1. Target Overview & Investment Thesis
KNAPP MEDICAL CENTER is a 162-bed suburban community hospital in HIDALGO, TX with $97.9M in net patient revenue and a -0.9% operating margin. The hospital serves a payer mix of 14.6% Medicare, 9.6% Medicaid, and 75.8% commercial.
Thesis: Undervalued. Our ML models identify $7.2M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from -0.9% to 6.4% (+736bps).
| Net Revenue HCRIS | $97.9M |
| Current EBITDA COMPUTED | $-913K |
| Operating Margin COMPUTED | -0.9% |
| Occupancy HCRIS | 44.2% |
| Revenue / Bed COMPUTED | $605K |
| Net-to-Gross HCRIS | 16.0% |
| Distress Probability ML | 49.8% |
2. Market Context & Competitive Position
TX has 583 Medicare-certified hospitals with a median operating margin of -0.7%. The target's margin of -0.9% places it below the state median. Among 159 size-comparable peers (81-324 beds), the median margin is 2.8%. The target's below-peer margin suggests operational improvement opportunity.
3. RCM Performance Analysis — Comparable Hospitals
Comps selected by bed count (81-324), prioritizing same-state peers. 159 hospitals in the comp set.
| Hospital | State | Beds | Revenue | Margin |
|---|---|---|---|---|
| KNAPP MEDICAL CENTER (Target) | TX | 162 | $97.9M | -0.9% |
| DELL CHILDRENS MEDICAL CENTER | TX | 262 | $901.9M | 25.5% |
| DRISCOLL CHILDRENS HOSPITAL | TX | 215 | $694.3M | 29.4% |
| ROUND ROCK HOSPITAL | TX | 165 | $681.4M | 8.7% |
| GOOD SHEPHERD MEDICAL CENTER | TX | 314 | $557.4M | 0.7% |
| HOUSTON METHODIST THE WOODLAND | TX | 292 | $535.9M | 13.9% |
| METHODIST WEST HOUSTON HOSPITA | TX | 270 | $529.7M | 15.5% |
| TEXAS HEALTH PRESBYTERIAN HOSP | TX | 305 | $499.6M | 14.7% |
| HILLCREST BAPTIST MEDICAL CENT | TX | 236 | $464.8M | -6.7% |
4. Predicted Improvement Opportunities
Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $7.2M (736bps margin improvement).
| Lever | Current | Target | EBITDA Impact | Margin | Ramp |
|---|---|---|---|---|---|
| Net Collection Rate | 93.5% | 97.0% | $2.1M | +210bp | 18mo |
| Cost to Collect | 4.5% | 2.5% | $2.0M | +200bp | 12mo |
| Denial Rate Reduction | 12.0% | 6.5% | $1.9M | +198bp | 12mo |
| A/R Days Reduction | 5200.0% | 3800.0% | $1.2M | +122bp | 9mo |
| Clean Claim Rate | 88.0% | 96.0% | $63K | +6bp | 6mo |
5. EBITDA Bridge
| Current EBITDA | $-913K |
| + RCM Uplift | +$7.2M |
| Pro Forma EBITDA | $6.3M |
| Current Margin | -0.9% |
| Pro Forma Margin | 6.4% |
| WC Released (1x) | $3.8M |
6. Returns Analysis — Scenario Matrix
5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.
| Scenario | Entry | Exit | Equity In | Equity Out | MOIC | IRR |
|---|---|---|---|---|---|---|
| Base Case | 10.0x | 10.0x | $-1.4M | $66.1M | 0.00x | -100.0% |
| Base (11x exit) | 10.0x | 11.0x | $-1.4M | $72.2M | 0.00x | -100.0% |
| Bull Case | 9.0x | 11.0x | $-1.3M | $95.5M | 0.00x | -100.0% |
| Bull (12x exit) | 9.0x | 12.0x | $-1.3M | $103.9M | 0.00x | -100.0% |
| Bear Case | 11.0x | 10.0x | $-1.5M | $30.5M | 0.00x | -100.0% |
| Bear (11x exit) | 11.0x | 11.0x | $-1.5M | $33.0M | 0.00x | -100.0% |
7. Key Risks & Mitigants
| Severity | Risk Factor | Mitigant |
|---|---|---|
| High | Negative operating margin | RCM uplift bridge shows clear path to profitability; working capital release provides near-term cash cushion |
| Low | Low net-to-gross ratio | Large contractual allowances suggest pricing discipline issues. Mitigant: payer renegotiation is an additional upside lever |
8. Data Sources & Methodology Appendix
Data Sources
- CMS HCRIS Cost Reports (Medicare-certified hospitals)
- CMS Medicare Utilization (DRG-level volumes)
- CMS Chronic Conditions (county-level disease prevalence)
- HCRIS multi-year trend data (financial time series)
Comparable Selection
- 159 hospitals with 81-324 beds
- Same-state prioritization (n=160)
- Comp margins: P25=-9.2% / P50=2.8% / P75=14.6%
Bridge Methodology
- Targets: P75 of comparable peers (60% gap closure)
- Denial: avoidable share = 35% of delta × NPR
- AR: bad debt coefficient = $0.65 per day per $1K NPR
- NCR: 60% coefficient on collection rate improvement
- CDI: 0.75% of Medicare revenue per 0.01 CMI point
Returns Assumptions
- Leverage: 5.5x entry (84.6% debt / 15.4% equity)
- Organic growth: 3% annual EBITDA growth
- Debt paydown: 10% of principal per year
- Hold period: 5 years
Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.